The Global Antifungal Drugs Market is poised to grow at a CAGR of around 1.8% over the next decade to reach approximately $12.8 billion by 2025.
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Some of the prominent trends that the market is witnessing include raising awareness amid public, developing public-private partnership in pharmaceutical industry, latest technological advancements in antifungal infection therapeutics and growth opportunities/investment opportunities.
Based on Drug type the market is categorized into polyenes, echinocandins, azoles, allylamines and other drug types. Depending on the Therapeutic Indication the market is segmented by dermatophytosis, candidiasis, aspergillosis and other therapeutic indications.
Depending on the Product form the market is segmented by tablets, shampoo, liquids or spray, injections, gels and cream. Based on Application the market is categorized into powders, pastes, ointments, drugs, other applications. Based on Distribution channel the market is categorized into retail pharmacies, hospital pharmacies, E-commerce, specialty clinics and other distribution channels.
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview 3.1 Current Trends 3.1.1 Raising awareness amid Public 3.1.2 Developing public-private partnership in pharmaceutical industry 3.1.3 Latest technological advancements in Antifungal infection Therapeutics 3.1.4 Growth opportunities/investment opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness
4 Antifungal Drugs Market, By Drug Type 4.1 Polyenes 18.104.22.168 Liposomal Amphotericin B Corifungin 22.214.171.124 Natamycin 126.96.36.199 Hamycin 188.8.131.52 Candicidin 184.108.40.206 Amphotericin B Deoxycholate 220.127.116.11 Nystatin 18.104.22.168 Other Polyenes 4.2 Echinocandins 22.214.171.124 Micafungin 126.96.36.199 Caspofungin 188.8.131.52 Pneumocandins 184.108.40.206 Anidulafungin 220.127.116.11 Other Echinocandins 4.3 Azoles 18.104.22.168 Voriconazole 22.214.171.124 Posaconazole 126.96.36.199 Thiazoles 188.8.131.52 Ketoconazole 184.108.40.206 Itraconazole 220.127.116.11 Imidazoles 18.104.22.168 Fluconazole 22.214.171.124 Other Azoles 4.4 Allylamines 126.96.36.199 Terbinafine 188.8.131.52 Lamisil 184.108.40.206 Other Allylamines 4.5 Other Drug types 220.127.116.11 Greisiofulvin 18.104.22.168 Ciclopirox 22.214.171.124 Benzoic Acid
6 Antifungal Drugs Market, By Product form 6.1 Tablets 6.2 Shampoo 6.3 Liquids or Spray 6.4 Injections 6.5 Gels 6.6 Cream
7 Antifungal Drugs Market, By Application 7.1 Powders 7.2 Pastes 7.3 Ointments 7.4 Drugs 7.5 Other Applications
8 Antifungal Drugs Market, By Distribution channel 8.1 Retail Pharmacies 8.2 Hospital Pharmacies 8.3 E-commerce 8.4 Specialty Clinics 8.5 Other Distribution channels 8.5.1 Other Distribution channels Market Forecast to 2025 (US$ MN)
9 Antifungal Drugs Market, By Geography
10 Key Player Activities 10.1 Acquisitions & Mergers 10.2 Agreements, Partnerships, Collaborations and Joint Ventures 10.3 Product Launch & Expansions 10.4 Other Activities
11 Leading Companies 11.1 Scynexis Inc. 11.2 Sanofi-Aventis 11.3 Pfizer Inc. 11.4 Novartis AG 11.5 Merck & Co. Inc 11.6 Kramer Laboratories 11.7 Johnson & Johnson 11.8 ID Sigma-Aldrich Corporation 11.11 Glenmark Pharmaceuticals Ltd 11.10 Glaxosmithkline 11.11 Enzon Pharmaceuticals 11.12 Bayer Healthcare 11.13 Astellas Pharma Inc 11.14 Asperqillus 11.15 Alternaria 11.16 Abbott Laboratories